Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 2Gynecologic 1

Conditions

Prostatic Neoplasms 2Uterine Neoplasms 1

Interventions

pembrolizumab 1262Specimen Handling 924Magnetic Resonance Spectroscopy 829Carboplatin 821Cyclophosphamide 799Cisplatin 722Nivolumab 667Paclitaxel 627Radiotherapy 608Gemcitabine 570Biopsy 557Bevacizumab 478Dexamethasone 437fludarabine 407Docetaxel 377venetoclax 367Oxaliplatin 364Capecitabine 355Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 329Drug Therapy 325Doxorubicin 316Radiosurgery 314Standard of Care 309Blood Specimen Collection 308Pemetrexed 304Ipilimumab 298Radiation 285

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Ultrasound, High-Intensity Focused, Transrectal × 1 year × Clear all
NCT06024772 2026-06-05

Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer

Thomas Jefferson University

Phase 3 Not yet recruiting
300 enrolled
Genitourinary

Prostatic Neoplasms

NCT05977621 2026-03-06

(TRUS)

Duke University

Recruiting
17 enrolled
Gynecologic

Uterine Neoplasms

NCT01990521 2025-09-09

Prostate Screening Study Using MRI in BRCA Carriers

Toronto Sunnybrook Regional Cancer Centre

Phase NA Active not recruiting
60 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡